MedPath

A comparative clinical trial to study the effect of Darvyadi Niruhabasti and Panchatikta Panchaprasrutik Basti in the management of Kitibha Kushtha(psoriasis)

Phase 2
Conditions
Health Condition 1: L40- Psoriasis
Registration Number
CTRI/2022/06/042961
Lead Sponsor
Parul Ayurved Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients presenting with clinical signs and symptoms of Kitibha Kushtha.

2. Kitibha Kushtha patients between the age group of 18 to 70 years.

3. Patients of either gender irrespective of caste and religion.

Exclusion Criteria

1. Patients having other systemic disorders - known case of Hypertension, Carcinoma, Tuberculosis, Infectious diseases and other life threatening disorders.

2. Patients contraindicated for Shodhana such as Pregnant & lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helps in reduction of signs and symptoms of psoriasis and recurrence of the disease will be controlled.Timepoint: 8 days of treatment <br/ ><br>After 15 days of treatment follow up
Secondary Outcome Measures
NameTimeMethod
There will be increased quality of life in psoriasis patients and complications of the disease will be reduced.Timepoint: 25 days
© Copyright 2025. All Rights Reserved by MedPath